Novel Therapeutics for Diabetes: Uptake, Usage Trends, and Comparative Effectiveness.

Abstract:

:The number of available therapies for treating type 2 diabetes has grown considerably in recent years. This growth has been fueled by availability of newer medications, whose benefits and risks have not been fully established. In this study, we review and synthesize the existing literature on the uptake, efficacy, safety, and cost-effectiveness of novel antidiabetic agents. Specifically, we focus on three drug classes that were introduced in the market recently: thiazolidinediones (TZDs), dipeptidyl peptidase-4 (DPP-4) inhibitors, and glucagon-like peptide-1 (GLP-1) receptor agonists. Not surprisingly, we find that the usage trends reflect the efficacy and safety profile of these novel drugs. The use of TZDs increased initially but decreased after a black-box warning was issued for rosiglitazone in 2007 that highlighted the cardiovascular risks associated with using the drug. Conversely, DPP-4 inhibitors and GLP-1 receptor agonists gained market shares due to their efficacy in glycemic control as an add-on treatment to metformin. DPP-4 inhibitors were the most commonly prescribed agents among the three novel drug classes, likely because they are relatively less expensive, have better safety profile, are administered orally, and are weight neutral. Sitagliptin was the most preferred DPP-4 inhibitor. The level of evidence on the comparative effectiveness, safety, and cost implications of using novel antidiabetic agents remains low and further studies with long-term follow-ups are needed.

journal_name

Curr Diab Rep

journal_title

Current diabetes reports

authors

Ahuja V,Chou CH

doi

10.1007/s11892-016-0744-4

subject

Has Abstract

pub_date

2016-06-01 00:00:00

pages

47

issue

6

eissn

1534-4827

issn

1539-0829

pii

10.1007/s11892-016-0744-4

journal_volume

16

pub_type

杂志文章,评审
  • The forgotten role of glucose effectiveness in the regulation of glucose tolerance.

    abstract::Glucose effectiveness (SG) is the ability of glucose per se to stimulate its own uptake and to suppress its own production under basal/constant insulin concentrations. In an individual, glucose tolerance is a function of insulin secretion, insulin action and SG. Under conditions of declining insulin secretion and acti...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0605-6

    authors: Dube S,Errazuriz-Cruzat I,Basu A,Basu R

    更新日期:2015-06-01 00:00:00

  • Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity.

    abstract::Diabetes mellitus and obesity have become increasingly prevalent problems worldwide. Unfortunately, with traditionally prescribed glucose-lowering medications most individuals with diagnosed diabetes do not achieve and maintain adequate glycemic control over time; it may be even more challenging to lower blood glucose...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-007-0060-0

    authors: Green JB,Feinglos MN

    更新日期:2007-10-01 00:00:00

  • Bioprinting an Artificial Pancreas for Type 1 Diabetes.

    abstract:PURPOSE OF REVIEW:Pancreatic islet cell transplantation is currently the only curative cell therapy for type 1 diabetes mellitus. However, its potential to treat many more patients is limited by several challenges. The emergence of 3D bioprinting technology from recent advances in 3D printing, biomaterials, and cell bi...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1166-x

    authors: Kim J,Kang K,Drogemuller CJ,Wallace GG,Coates PT

    更新日期:2019-07-04 00:00:00

  • Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes.

    abstract::Type 1 and type 2 diabetes both accelerate cardiovascular disease, yet the triggers are likely different for the two types of diabetes. Results from large-scale clinical trials suggest that intense blood glucose control can reduce cardiovascular events many years later in patients with type 1 diabetes. In type 2 diabe...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-009-0005-x

    authors: Averill MM,Bornfeldt KE

    更新日期:2009-02-01 00:00:00

  • Diabetic Kidney Disease: Is There a Role for Glycemic Variability?

    abstract:PURPOSE OF REVIEW:Diabetes is the leading cause of kidney disease globally. Diabetic kidney disease (DKD) is a heterogeneous disorder manifested as albuminuria and/or decreasing GFR. Hyperglycemic burden is the major contributor to the development of DKD. In this article, we review the evidence for the contribution of ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-018-0979-3

    authors: Subramanian S,Hirsch IB

    更新日期:2018-02-15 00:00:00

  • Nutrition Transition and the Global Diabetes Epidemic.

    abstract::Low- and middle-income countries (LMICs) face a rapid change in the nutrition transition toward increases in noncommunicable diseases. Underlying this transition are shifts in the agricultural system and the subsequent growth of the modern retail and food service sectors across all regions and countries, a change in t...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0631-4

    authors: Popkin BM

    更新日期:2015-09-01 00:00:00

  • Metabolic syndrome and cardiometabolic risk in PCOS.

    abstract::The cardiovascular risk associated with the polycystic ovary syndrome (PCOS) has recently attracted much interest. Women with PCOS are more likely to fulfill the diagnosis of the metabolic syndrome, a cluster of related cardiometabolic factors known to predict long-term risk of cardiovascular disease and type 2 diabet...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-007-0012-8

    authors: Cussons AJ,Stuckey BG,Watts GF

    更新日期:2007-02-01 00:00:00

  • Therapeutic Strategies for Modulating the Extracellular Matrix to Improve Pancreatic Islet Function and Survival After Transplantation.

    abstract:PURPOSES OF REVIEW:Extracellular matrix (ECM) components modulate the interaction between pancreatic islet cells. During the islet isolation prior to transplantation as treatment for type 1 diabetes, the ECM is disrupted impacting functional graft survival. Recently, strategies for restoring ECM have shown to improve t...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-018-1014-4

    authors: Smink AM,de Vos P

    更新日期:2018-05-19 00:00:00

  • Gut Microbiome in Obesity, Metabolic Syndrome, and Diabetes.

    abstract:PURPOSE OF REVIEW:Obesity and diabetes are worldwide epidemics. There is also a growing body of evidence relating the gut microbiome composition to insulin resistance. The purpose of this review is to delineate the studies linking gut microbiota to obesity, metabolic syndrome, and diabetes. RECENT FINDINGS:Animal stud...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-018-1104-3

    authors: Chen X,Devaraj S

    更新日期:2018-10-18 00:00:00

  • Oxidative stress and endothelial dysfunction in vascular disease.

    abstract::In response to physiologic stimuli, endothelial cells dynamically regulate arterial vascular tone by producing vasodilators and vasoconstrictors. Risk factors for atherosclerosis, such as diabetes, smoking, hypercholesterolemia, and hypertension, interfere with this response, promoting endothelial dysfunction and athe...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-007-0041-3

    authors: Pennathur S,Heinecke JW

    更新日期:2007-08-01 00:00:00

  • The distinctive nature of atherosclerotic vascular disease in diabetes: pathophysiological and morphological insights.

    abstract::As the incidence of diabetes mellitus continues to rise, parallel increases in the rates of diabetic atherosclerotic vascular disease are projected to impart major health and socioeconomic challenges for authorities worldwide. Diabetes results in a proatherogenic phenotype, manifesting in an accelerated, diffuse, poly...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-012-0270-y

    authors: Puri R,Kataoka Y,Uno K,Nicholls SJ

    更新日期:2012-06-01 00:00:00

  • Nutrition therapy for dyslipidemia.

    abstract::National guidelines indicate patients with elevated low- density lipoprotein cholesterol should consume less than 7% of calories from saturated fat and less than 200 mg of cholesterol. Trans fatty acids should also be limited. Incorporation of functional foods, such as stanol-containing margarine, soy products, and so...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-003-0084-z

    authors: Carson JA

    更新日期:2003-10-01 00:00:00

  • Diabetic foot disease in people with advanced nephropathy and those on renal dialysis.

    abstract::Among the spectrum of risk for diabetic foot disease conferred by chronic kidney disease (CKD), end-stage renal disease (ESRD) has emerged as a novel independent risk factor. Apart from the classical triad of neuropathy, infection, and peripheral arterial disease that operate in these individuals, the risk is further ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-010-0128-0

    authors: Ndip A,Lavery LA,Boulton AJ

    更新日期:2010-08-01 00:00:00

  • Understanding and enhancing adherence in adults with diabetes.

    abstract::This article reviews selected recent literature on adult diabetes patient-centered adherence to diabetes care recommendations. We describe more fully a limited number of articles that have particular lessons for diabetes clinicians and researchers. Each article was reviewed for methodology, adherence measures, and typ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-003-0038-5

    authors: Walker EA,Usher JA

    更新日期:2003-04-01 00:00:00

  • The use of bolus insulin and advancing insulin therapy in type 2 diabetes.

    abstract::Attention to meal-related insulin replacement in type 2 diabetes is important as insulin deficiency progresses. The physiology in type 2 and type 1 diabetes differs, and optimal use of basal-bolus therapy in type 2 diabetes requires attention to such issues as the role for oral medications, residual endogenous insulin...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-004-0037-1

    authors: Karl DM

    更新日期:2004-10-01 00:00:00

  • Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications.

    abstract::Hyperglycemia and dyslipidemia are significant and independent risk factors for the vascular complications in patients with diabetes. They have been suggested to cause cardiovascular pathologic changes in diabetic states through the following molecular mechanisms: formation and accumulation of advanced glycation end p...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-005-0034-z

    authors: Xu Y,He Z,King GL

    更新日期:2005-04-01 00:00:00

  • Drugs on the horizon for diabesity.

    abstract::The coexistence of type 2 diabetes and obesity presents a complex therapeutic challenge. Future combination tablets may include agents to address diabetes and any accompanying cardiovascular risk factors. Injectable agents that improve glycemic control and facilitate weight loss have recently become available: the sol...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-005-0093-1

    authors: Bailey CJ

    更新日期:2005-10-01 00:00:00

  • Role of Senescent Renal Cells in Pathophysiology of Diabetic Kidney Disease.

    abstract:PURPOSE OF REVIEW:Diabetic kidney disease (DKD) is the leading cause of kidney failure in the USA, representing ~ 44% of all cases of kidney failure. Advancements in both glucose management and inhibitors of the renin-angiotensin system have significantly improved prognosis for individuals with DKD, yet DKD continues t...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-01314-y

    authors: Wiley CD

    更新日期:2020-06-16 00:00:00

  • Erectile dysfunction: interrelationship with the metabolic syndrome.

    abstract::Erectile dysfunction (ED) is more commonly seen in men with various components of the metabolic syndrome (a constellation of various cardiovascular and diabetes risk factors). ED can be considered as a risk marker of the metabolic syndrome and its associated conditions. The patient with ED should be thoroughly evaluat...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-005-0070-8

    authors: Matfin G,Jawa A,Fonseca VA

    更新日期:2005-02-01 00:00:00

  • Thyroid Hormone Signalling Alteration in Diabetic Nephropathy and Cardiomyopathy: a "Switch" to the Foetal Gene Programme.

    abstract:PURPOSE OF THE REVIEW:In this study, we will analyse how diabetes induces the reactivation of organs' developmental programmes and growth, discuss how thyroid hormone (TH) signalling orchestrates these processes, and suggest novel strategies for exploiting TH-mediated reparative and regenerative properties. RECENT FIN...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-01344-6

    authors: Mantzouratou P,Lavecchia AM,Novelli R,Xinaris C

    更新日期:2020-09-28 00:00:00

  • Brain Stimulation to Modulate Food Intake and Eating Behavior.

    abstract:PURPOSE OF REVIEW:Appetitive behaviors are mediated through homeostatic and reward signaling of brain circuits. There has been increasing interest in the use of neuromodulation techniques aimed at targeting brain regions such as the lateral prefrontal and subcortical regions associated with dysregulation of eating beha...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1250-2

    authors: Dendy R,Stinson EJ,Guerithault N,Gluck ME

    更新日期:2019-12-02 00:00:00

  • Pathophysiology of prediabetes.

    abstract::The term prediabetes refers to subjects with impaired fasting glucose and/or impaired glucose tolerance who are at increased risk for type 2 diabetes mellitus. Although both types of patients are at increased risk for developing type 2 diabetes mellitus and cardiovascular disease, they manifest distinct metabolic abno...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-009-0032-7

    authors: Abdul-Ghani MA,DeFronzo RA

    更新日期:2009-06-01 00:00:00

  • Progression of β-cell dysfunction in obese youth.

    abstract::The epidemic of childhood obesity has led to a remarkable increase in the prevalence of type 2 diabetes (T2D) among youth worldwide. The decreasing age at onset of T2D has alarming public health implications. In particular, the longer duration of the disease, as well as the faster onset and progression of T2D related ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-012-0347-7

    authors: Giannini C,Caprio S

    更新日期:2013-02-01 00:00:00

  • Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.

    abstract::Fasting glucose and hemoglobin A1c (HbA1c) are the standard measures for diagnosis and monitoring of diabetes. There has been recent interest in nontraditional markers of hyperglycemia, including fructosamine, glycated albumin, and 1,5-anhydroglucitol (1,5-AG), as alternatives or adjuncts to standard measures. There i...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-014-0548-3

    authors: Parrinello CM,Selvin E

    更新日期:2014-01-01 00:00:00

  • Urogenital Autonomic Dysfunction in Diabetes.

    abstract::This review details the epidemiology, possible mechanisms, and risk factors associated with urogenital autonomic dysfunction in diabetes. Autonomic neuropathy in diabetes is associated with various urological complications including bladder and sexual dysfunction. Several studies have reported the high prevalence of b...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-016-0824-5

    authors: Braffett BH,Wessells H,Sarma AV

    更新日期:2016-12-01 00:00:00

  • Evidence and Challenges for Translation and Population Impact of the Diabetes Prevention Program.

    abstract:PURPOSE OF REVIEW:Type 2 diabetes is common, burdensome, and preventable. Landmark trials such as the Diabetes Prevention Program (DPP) demonstrated that resource-intensive lifestyle support interventions resulting in modest weight loss via healthy diet changes and physical activity can lower the rate of diabetes devel...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-1293-4

    authors: Ackermann RT,O'Brien MJ

    更新日期:2020-02-20 00:00:00

  • Predictive Mathematical Models of Weight Loss.

    abstract:PURPOSE OF REVIEW:Validated thermodynamic energy balance models that predict weight change are ever more in use today. Delivery of model predictions using web-based applets and/or smart phones has transformed these models into viable clinical tools. Here, we provide the general framework for thermodynamic energy balanc...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1207-5

    authors: Thomas DM,Scioletti M,Heymsfield SB

    更新日期:2019-08-31 00:00:00

  • Transplantation of xenogeneic islets: are we there yet?

    abstract::Beta cell replacement therapy has been proposed as a novel therapy for the treatment of type 1 diabetes. The proof of concept has been demonstrated with successful islet allotransplantation. Islet xenotransplantation has been proposed as an alternative, more reliable, and infinite source of beta cells. The advantages ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-013-0413-9

    authors: O'Connell PJ,Cowan PJ,Hawthorne WJ,Yi S,Lew AM

    更新日期:2013-10-01 00:00:00

  • Is Stem Cell Transplantation Ready for Prime Time in Diabetic Polyneuropathy?

    abstract::Diabetic polyneuropathy (DPN) is the most common complication that emerges early in patients who have diabetes. Curative treatment for overt or symptomatic DPN has not been established, requiring much effort to explore new modalities. Thus, the use of various kinds of stem cells as a potential therapeutic option for D...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-016-0776-9

    authors: Mizukami H,Yagihashi S

    更新日期:2016-09-01 00:00:00

  • The role of HNF4A variants in the risk of type 2 diabetes.

    abstract::Genes influence susceptibility to type 2 diabetes mellitus (T2DM), and both positional cloning and candidate gene approaches have been used to identify these genes. Linkage analysis has generated evidence for T2DM-predisposing variants on chromosome 20q in studies of Caucasians, Asians, and Africans, and fine-mapping ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-005-0043-y

    authors: Mohlke KL,Boehnke M

    更新日期:2005-04-01 00:00:00